|
| |
| | | 67446 | | 24.03.2020 | | Novo Nordisk Pharma AG | | | | | | | 23.03.2025 | | | | | | 07.06.20. | | | | 07.06.20. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Rybelsus 3 mg | Tabletten | Tabletten (Semaglutidum 3 mg) | A10BJ06 | PI | | 02 | Rybelsus 7 mg | Tabletten | Tabletten (Semaglutidum 7 mg) | A10BJ06 | | | 03 | Rybelsus 14 mg | Tabletten | Tabletten (Semaglutidum 14 mg) | A10BJ06 | |
|
|
|
